Facebook Linkedin RSS Twitter Youtube
Home 2024

Inflammatory bowel disease

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

Biodegradable Microrobots Deliver Therapies to Treat Inflammatory Bowel Disease in Mice
News

Biodegradable Microrobots Deliver Therapies to Treat Inflammatory Bowel Disease in Mice

Lab-Grown “Mini-Guts” Link Crohn’s Disease Severity to Epigenetic Changes
Featured

Lab-Grown “Mini-Guts” Link Crohn’s Disease Severity to Epigenetic Changes

Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cells
News

Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cells

CAR and Mesenchymal Stromal Cells Combine to Enhance Autoimmune Disease Immunotherapy
News

CAR and Mesenchymal Stromal Cells Combine to Enhance Autoimmune Disease Immunotherapy

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

Insilico Doses First Patient with AI-Designed IBD Treatment
Artificial Intelligence

Insilico Doses First Patient with AI-Designed IBD Treatment

Colonic Organoids Generate Functional Resident Macrophages
News

Colonic Organoids Generate Functional Resident Macrophages

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO
Drug Discovery

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO

123...25Page 1 of 25
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.